Bordetella pertussis strain variation and evolution postvaccination

References

• Pertussis (whooping cough). In: WHO-recommended standards for surveillance of selected vaccine-preventable diseases. WHO, Geneva, Switzerland (2003).
   Google Scholar
• Halperin SA. The control of pertussis: 2007 and beyond. N. Engl. J. Med.356(2), 110–113 (2007).
   PubMed Web of Science ®Google Scholar
• Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE. Resurgence of pertussis in Europe. Pediatr. Infect. Dis. J.24(9), 761–765 (2005).
   PubMed Web of Science ®Google Scholar
• Mooi FR, van Loo IH, King AJ. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg. Infect. Dis.7(3 Suppl.), 526–528 (2001).
   PubMed Web of Science ®Google Scholar
• Gzyl A, Augustynowicz E, Rabczenko D, Gniadek G, Slusarczyk J. Pertussis in Poland. Int. J. Epidemiol.33(2), 358–365 (2004).
   PubMed Web of Science ®Google Scholar
• Elomaa A, Advani A, Donnelly D et al. Strain variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years. J. Clin. Microbiol.43(8), 3681–3687 (2005).
   PubMed Web of Science ®Google Scholar
• Ntezayabo B, De Serres G, Duval B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr. Infect. Dis. J.22(1), 22–27 (2003).
   PubMed Web of Science ®Google Scholar
• McIntyre P, Gidding H, Gilmour R et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000. Commun. Dis. Intell. (Suppl. i–xi), 1–111 (2002).
   Google Scholar
• Lee YS, Yang CY, Lu CH, Tseng YH. Molecular epidemiology of Bordetella pertussis isolated in Taiwan, 1992–1997. Microbiol. Immunol.47(12), 903–909 (2003).
   PubMed Web of Science ®Google Scholar
• Moerman L, Leventhal A, Slater PE, Anis E, Yishai R, Marva E. The re-emergence of pertussis in Israel. Isr. Med. Assoc. J.8(5), 308–311 (2006).
   PubMed Web of Science ®Google Scholar
• Pertussis vaccines: WHO position paper. Wkly Epidemiol. Rec.80(4), 31–39 (2005).
   PubMedGoogle Scholar
• Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine25(14), 2634–2642 (2007).
   PubMed Web of Science ®Google Scholar
• Parkhill J, Sebaihia M, Preston A et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat. Genet.35(1), 32–40 (2003).
   PubMed Web of Science ®Google Scholar
• Caro V, Hot D, Guigon G et al. Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization. Microbes Infect.8(8), 2228–2235 (2006).
   PubMed Web of Science ®Google Scholar
• Heikkinen E, Kallonen T, Saarinen L et al. Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains. PLoS ONE2(9), e904 (2007).
   Google Scholar
• King AJ, van Gorkom T, Pennings JL et al. Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains. BMC Genomics9, 311 (2008).
   PubMedGoogle Scholar
• Mooi FR, Hallander H, Wirsing von Konig CH, Hoet B, Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. J. Clin. Microbiol. Infect. Dis.19(3), 174–181 (2000).
   PubMed Web of Science ®Google Scholar
• Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immun.66(2), 670–675 (1998).
   PubMed Web of Science ®Google Scholar
• Mooi FR, He Q, van Oirschot H, Mertsola J. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect. Immun.67(6), 3133–3134 (1999).
   PubMed Web of Science ®Google Scholar
• Cassiday P, Sanden G, Heuvelman K, Mooi F, Bisgard KM, Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935–1999. J. Infect. Dis.182(5), 1402–1408 (2000).
   PubMed Web of Science ®Google Scholar
• Tsang RS, Lau AK, Sill ML et al. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J. Clin. Microbiol.42(11), 5364–5367 (2004).
   PubMed Web of Science ®Google Scholar
• Weber C, Boursaux-Eude C, Coralie G, Caro V, Guiso N. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J. Clin. Microbiol.39(12), 4396–4403 (2001).
   PubMed Web of Science ®Google Scholar
• Hallander HO, Advani A, Donnelly D, Gustafsson L, Carlsson RM. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J. Clin. Microbiol.43(6), 2856–2865 (2005).
   PubMed Web of Science ®Google Scholar
• Caro V, Njamkepo E, Van Amersfoorth SC et al. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect.7(7–8), 976–982 (2005).
   PubMed Web of Science ®Google Scholar
• Schouls LM, van der Heide HG, Vauterin L, Vauterin P, Mooi FR. Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J. Bacteriol.186(16), 5496–5505 (2004).
   PubMed Web of Science ®Google Scholar
• van Amersfoorth SC, Schouls LM, van der Heide HG et al. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J. Clin. Microbiol.43(6), 2837–2843 (2005).
   PubMed Web of Science ®Google Scholar
• Elomaa A, Advani A, Donnelly D et al. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine25(5), 918–926 (2007).
   PubMed Web of Science ®Google Scholar
• Bouchez V, Caro V, Levillain E, Guigon G, Guiso N. Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoS ONE3(6), e2437 (2008).
   PubMed Web of Science ®Google Scholar
• Eldering G, Holwerda J, Davis A, Baker J. Bordetella pertussis serotypes in the United States. Appl. Microbiol.18(4), 618–621 (1969).
   PubMedGoogle Scholar
• Bronne-Shanbury C, Miller D, Standfast AF. The serotypes of Bordetella pertussis isolated in Great Britain between 1941 and 1968 and a comparison with the serotypes observed in other countries over this period. J. Hyg. (Lond.)76(2), 265–275 (1976).
   PubMedGoogle Scholar
• Miller E, Vurdien JE, White JM. The epidemiology of pertussis in England and Wales. Commun. Dis. Rep. CDR Rev.2(13), R152–R154 (1992).
   Google Scholar
• Preston NW, Carter EJ. Serotype specificity of vaccine-induced immunity to pertussis. Commun. Dis. Rep. CDR Rev.2(13), R155–R156 (1992).
   PubMedGoogle Scholar
• Van Loo IH, Mooi FR. Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines. Microbiology148(Pt 7), 2011–2018 (2002).
   PubMed Web of Science ®Google Scholar
• Caro V, Elomaa A, Brun D, Mertsola J, He Q, Guiso N. Bordetella pertussis, Finland and France. Emerg. Infect. Dis.12(6), 987–989 (2006).
   PubMed Web of Science ®Google Scholar
• Borisova O, Kombarova SY, Zakharova NS et al. Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains. Clin. Vaccine Immunol.14(3), 234–238 (2007).
   PubMedGoogle Scholar
• Poolman JT, Hallander HO. Acellular pertussis vaccines and the role of pertactin and fimbriae. Expert Rev. Vaccines6(1), 47–56 (2007).
   PubMed Web of Science ®Google Scholar
• Preziosi MP, Yam A, Wassilak SG et al. Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program. Am. J. Epidemiol.155(10), 891–896 (2002).
   PubMed Web of Science ®Google Scholar
• Njamkepo E, Cantinelli T, Guigon G, Guiso N. Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas. Microbes Infect.10(14–15), 1582–1586 (2008).
   PubMed Web of Science ®Google Scholar
• van Loo IH, Heuvelman KJ, King AJ, Mooi FR. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J. Clin. Microbiol.40(6), 1994–2001 (2002).
   PubMed Web of Science ®Google Scholar
• Packard ER, Parton R, Coote JG, Fry NK. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J. Med. Microbiol.53(Pt 5), 355–365 (2004).
   PubMed Web of Science ®Google Scholar
• He Q, Mertsola J. Factors contributing to pertussis resurgence. Future Microbiol.3, 329–339 (2008).
   PubMed Web of Science ®Google Scholar
• Peppler MS, Kuny S, Nevesinjac A et al. Strain variation among Bordetella pertussis isolates from Quebec and Alberta provinces of Canada from 1985 to 1994. J. Clin. Microbiol.41(7), 3344–3347 (2003).
   PubMed Web of Science ®Google Scholar
• Fingermann M, Fernandez J, Sisti F et al. Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production. Vaccine24(17), 3513–3521 (2006).
   PubMed Web of Science ®Google Scholar
• Lin YC, Yao SM, Yan JJ et al. Molecular epidemiology of Bordetella pertussis in Taiwan, 1993–2004: suggests one possible explanation for the outbreak of pertussis in 1997. Microbes Infect.8(8), 2082–2087 (2006).
   PubMed Web of Science ®Google Scholar
• Kodama A, Kamachi K, Horiuchi Y, Konda T, Arakawa Y. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J. Clin. Microbiol.42(12), 5453–5457 (2004).
   PubMed Web of Science ®Google Scholar
• Gzyl A, Augustynowicz E, van Loo I, Slusarczyk J. Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine20(3–4), 299–303 (2001).
   PubMed Web of Science ®Google Scholar
• Fiett J, Letowska I, Gniadkowski M, Hryniewicz W. The new strategy for allele identification of the genes coding for pertussis toxin subunit S1 (ptx S1) and pertactin (prn) in Bordetella pertussis. J. Microbiol. Methods55(3), 651–666 (2003).
   PubMed Web of Science ®Google Scholar
• Fry NK, Neal S, Harrison TG, Miller E, Matthews R, George RC. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect. Immun.69(9), 5520–5528 (2001).
   PubMed Web of Science ®Google Scholar
• Poynten M, McIntyre PB, Mooi FR, Heuvelman KJ, Gilbert GL. Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol. Infect.132(2), 185–193 (2004).
   PubMed Web of Science ®Google Scholar
• Wang J, Yang Y, Li J et al. Infantile pertussis rediscovered in China. Emerg. Infect. Dis.8(8), 859–861 (2002).
   PubMed Web of Science ®Google Scholar
• Mastrantonio P, Spigaglia P, van Oirschot H et al. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology145(Pt 8), 2069–2075 (1999).
   PubMed Web of Science ®Google Scholar
• Sato Y, Kimura M, Fukumi H. Development of a pertussis component vaccine in Japan. Lancet1(8369), 122–126 (1984).
   PubMed Web of Science ®Google Scholar
• Sato Y, Sato H. Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers. Tokai J. Exp. Clin. Med.13(Suppl.), 79–88 (1988).
   PubMedGoogle Scholar
• Watanabe M, Nagai M. Acellular pertussis vaccines in Japan: past, present and future. Expert Rev. Vaccines4(2), 173–184 (2005).
   PubMed Web of Science ®Google Scholar
• Godfroid F, Denoel P, Poolman J. Are vaccination programs and isolate polymorphism linked to pertussis re-emergence? Expert Rev. Vaccines4(5), 757–778 (2005).
   PubMed Web of Science ®Google Scholar
• Guiso N, Boursaux-Eude C, Weber C et al. Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines. Vaccine19(23–24), 3248–3252 (2001).
   PubMed Web of Science ®Google Scholar
• Advani A, Gustafsson L, Carlsson RM, Donnelly D, Hallander HO. Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype. APMIS115(6), 736–742 (2007).
   PubMed Web of Science ®Google Scholar
• Advani A, Donnelly D, Gustafsson L, Hallander HO. Changes of the Swedish Bordetella pertussis population in incidence peaks during an acellular pertussis vaccine period between 1997 and 2004. APMIS115(4), 299–310 (2007).
   PubMed Web of Science ®Google Scholar
• Hallander H, Advani A, Riffelmann M et al.Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J. Clin. Microbiol.45(10), 3257–3262 (2007).
   PubMed Web of Science ®Google Scholar
• Hardwick TH, Cassiday P, Weyant RS, Bisgard KM, Sanden GN. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg. Infect. Dis.8(1), 44–49 (2002).
   PubMed Web of Science ®Google Scholar
• van Loo IH, van der Heide HG, Nagelkerke NJ, Verhoef J, Mooi FR. Temporal trends in the population structure of Bordetella pertussis during 1949–1996 in a highly vaccinated population. J. Infect. Dis.179(4), 915–923 (1999).
   PubMed Web of Science ®Google Scholar
• Caro V, Bouchez V, Guiso N, Gatti B, Agosti MR, Ayala SE. Pertussis in Argentina and France. Vaccine25(22), 4335–4339 (2007).
   PubMed Web of Science ®Google Scholar
• Brinig MM, Cummings CA, Sanden GN, Stefanelli P, Lawrence A, Relman DA. Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. J. Bacteriol.188(7), 2375–2382 (2006).
   PubMed Web of Science ®Google Scholar
• Heikkinen E, Xing DK, Olander RM et al.Bordetella pertussis isolates in Finland: serotype and fimbrial expression. BMC Microbiol.8, 162 (2008).
   PubMedGoogle Scholar
• Kasuga T, Nakase Y, Ukishima K, Takatsu K. Studies on Haemophilis pertussis. III. Some properties of each phase of H. pertussis. Kitasato Arch. Exp. Med.27(3), 37–47 (1954).
   PubMedGoogle Scholar
• Cummings CA, Brinig MM, Lepp PW, van de Pas S, Relman DA. Bordetella species are distinguished by patterns of substantial gene loss and host adaptation. J. Bacteriol.186(5), 1484–1492 (2004).
   PubMed Web of Science ®Google Scholar
• Hot D, Antoine R, Renauld-Mongenie G et al. Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis. Mol. Genet. Genomics269(4), 475–486 (2003).
   PubMed Web of Science ®Google Scholar
• Maharjan RP, Gu C, Reeves PR, Sintchenko V, Gilbert GL, Lan R. Genome-wide analysis of single nucleotide polymorphisms in Bordetella pertussis using comparative genomic sequencing. Res. Microbiol.159(9–10), 602–608 (2008).
   PubMed Web of Science ®Google Scholar
• Goyard S, Bellalou J, Mireau H, Ullmann A. Mutations in the Bordetella pertussis bvgS gene that confer altered expression of the fhaB gene in Escherichia coli. J. Bacteriol.176(16), 5163–5166 (1994).
   PubMed Web of Science ®Google Scholar
• Fennelly NK, Sisti F, Higgins SC et al.Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses. Infect. Immun.76(3), 1257–1266 (2008).
   PubMed Web of Science ®Google Scholar
• Tsang RS, Sill ML, Advani A, Xing D, Newland P, Hallander H. Use of monoclonal antibodies to serotype Bordetella pertussis isolates: comparison of results obtained by indirect whole-cell enzyme-linked immunosorbent assay and bacterial microagglutination methods. J. Clin. Microbiol.43(5), 2449–2451 (2005).
   PubMed Web of Science ®Google Scholar
• van der Zee A, Vernooij S, Peeters M, van Embden J, Mooi FR. Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution. Microbiology142(Pt 12), 3479–3485 (1996).
   PubMed Web of Science ®Google Scholar
• Antila M, He Q, de Jong C et al.Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. J. Med. Microbiol.55(Pt 8), 1043–1051 (2006).
   PubMed Web of Science ®Google Scholar
• Advani A, Donnelly D, Hallander H. Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles. J. Clin. Microbiol.42(7), 2890–2897 (2004).
   PubMed Web of Science ®Google Scholar
• Bottero D, Gaillard ME, Fingermann M et al. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin. Vaccine Immunol.14(11), 1490–1498 (2007).
   PubMedGoogle Scholar
• Lee MS, Lee YS, Chiou CS. The suitable restriction enzymes for pulsed-field gel electrophoresis analysis of Bordetella pertussis. Diagn. Microbiol. Infect. Dis.56(2), 217–219 (2006).
   PubMed Web of Science ®Google Scholar
• Boursaux-Eude C, Thiberge S, Carletti G, Guiso N. Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine. Vaccine17(20–21), 2651–2660 (1999).
   PubMed Web of Science ®Google Scholar
• Denoel P, Godfroid F, Guiso N, Hallander H, Poolman J. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model. Vaccine23(46–47), 5333–5341 (2005).
   PubMed Web of Science ®Google Scholar
• Gzyl A, Augustynowicz E, Gniadek G, Rabczenko D, Dulny G, Slusarczyk J. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates. Vaccine22(17–18), 2122–2128 (2004).
   PubMed Web of Science ®Google Scholar
• King AJ, Berbers G, van Oirschot HF, Hoogerhout P, Knipping K, Mooi FR. Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiology147(Pt 11), 2885–2895 (2001).
   PubMed Web of Science ®Google Scholar
• Hausman SZ, Burns DL. Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization. Infect. Immun.68(6), 3763–3767 (2000).
   PubMed Web of Science ®Google Scholar
• de Greeff SC, Mooi FR, Schellekens JF, de Melker HE. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr. Infect. Dis. J.27(3), 218–223 (2008).
   PubMed Web of Science ®Google Scholar
• He Q, Makinen J, Berbers G et al.Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants? J. Infect. Dis.187(8), 1200–1205 (2003).
   PubMed Web of Science ®Google Scholar
• Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine16(20), 1901–1906 (1998).
   PubMed Web of Science ®Google Scholar
• Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine16(20), 1907–1916 (1998).
   PubMed Web of Science ®Google Scholar
• Hellwig SM, Rodriguez ME, Berbers GA, van de Winkel JG, Mooi FR. Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J. Infect. Dis.188(5), 738–742 (2003).
   PubMed Web of Science ®Google Scholar
• Aguas R, Goncalves G, Gomes MG. Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infect. Dis.6(2), 112–117 (2006).
   PubMed Web of Science ®Google Scholar